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I.	 INTRODUCTION
This is the final report under Purchase Order T-477713 for studying the feasi-
bility of developing a fetal measurement clectrode system.
This report summarizes findings of the study, concludes that all monitoring
requirements are not currently satisfied, and presents an approach to provide
a multiparametric monitoring system through combinations of existing trans-
ducers. This monitoring system would be appropriate, not only for intraparLUm
monitoring, but also for neonatal and adult blood gas evaluations.
During this study, a literature search was conducted to provide an insight into
current- state-of-the-art in fetal monitoring. A reference list in this report
includes all literature cited in the report, plus many others containing back-
ground and supplementary information. A separately-bound volume accompanying
this reporL--Materials Collected During Contract Period--contains reprints of
all listed references.
lI.	 CURRENT STATE-OP-THE-ART
The primary purpose of monitoring the fetus during the critical delivery period
Is to detect evidence of hypoxia, i.e., lack of oxygen to the fetus. Limited
oxygen availability to the fetus can cause irreversible brain damage and even
death.
As reviewed by 7,iehm, l auscultation of the fetal heart was begun early in the	 i
19th century. Listening to the fetal. heart sounds with the fetal stethoscope
was then, and continues to be, an intermittent procedure, usually Hone between	 j
labor contractions.
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Initially the relationship of Petal Heart Rate (P11R) to hypoxia was not well
understood, but with the advent of continuous fetal heart rate monitoring--both
between and during labor contractions--it has become accepted that hypoxia can
cause significant changes in fetal heart rates. Spurett 2 reports that in the
early 1960's lion and Caldeyro-Barcin investigated PHR monitoring by direct
connection of an electrode to the fetal scalp. This work led to the concept
of simultaneous intrauterine pressure recording (IUP) and fetal beat-by-beat
analysis and recording of PHR and IUP on a two-channel recorder at a relatively
slow chart speed.
This direct• approach is relatively artifact-free, although its application is
delayed until the amnion is ruptured and fetal presenting-part of a size suit-
able for electrode attachment is available. Indirect approaches--using micro-
phones, ultrasonic transducers, and abdominal pressure transducers--although
applicable in early stages of labor, are artifact prone and consequently less
dependable.
Experience with the P1IR-IUP patterns lead to fairly clear categorization of Plitt
patterns with ominous indications. Persistant tachycardia, recurrent decelera-
tion patterns, or limited beat-to-beat irregularity lasting 20 minutes or more,
are examples of major signs which may indicate a fetus in danger. 2 Inservice
hospieal training has brought physician and nurse skills to a level. where PI1R
patterns are now well. understood and arc employed to manage the patient durin;
delivery.
Because 171IR is only an indirect indicator of hypoxia, other methods of analzing
fetal well-being were investigated. In 1962, Saling described a method of
sampling blood from the presenting fetal part, which is the scalp about- 95% of
the time. 2 Petal scalp blood sampling (FSB) is an intermittent procedure; but,
as employed in today's obstetric environment, the frequency of and the precise
instant for .sampling Is guided by the PHR and/or IUP patterns. It is well es-
tablished that an acidotic state, indicated by p1l analysis of the PSB, indicates
hypoxia of the fetus. 3 It has been shown that• maternal acid-base shifts may be
reflected into the fetus due to ion transfer across the pl.acenta. 4 Because of
rR-121.7 -1.01. 	 -2-
this possible confusion as to the cause of fetal acid-base shift, maternal blood
gas analysis concomitant with PSB analysis is recommended.
The addition of periodic PSB pIl sampling to the continuous PHR-IUP monitoring
reduced the false negative indications to an acceptable minimum; i.e., although
the P1111 patterns may appear ominous at times, a normal (>7.25 pll) PSB pll taken
frequently is indicative of an acceptable Apgar score.3,4
Remaining unresolved Is the situation where PHR patterns and PSB pH are normal
but an infant with low Apgar score is born. In this case, the delivery team is
lulled into a false sense of security, and delays delivery (often by C-sec Lion)
until a damaged infant result's.
There remains in fetal monitoring today the need for a more definitive measure
of the fetal acid-base balance. This fetal acid-base indicator should be !on-
cinuous so that a characteristic phasic relationship between maternal conLrac-
tions, PIIR patterns, and fetal acid-base call learned and used to manage the
delivery.
The simultaneous measurement- of PIIR, P0 2 , and PCO 2
 or pll from the fetal scalp
appears to be the ideal solution. The P02 would indicate the initial transient
drop in fecal P0 2 during contractions and other, manipulations while the pH or
PCO2
 would indicate the resulting delayed acid-base shift due to significant
hypoxic periods.
The benefits of fetal monitoring are not universally accepted, however. The
conservative nature of medical practice has perhaps resisted the immediate sweep
to fetal monitoring into non-teaching hospitals. Common reasons for resisting
the introduction of fetal monitoring are increased Caesarean section rates
(C-rates) and additional costs. Another is the statement, "We only have a few
high risk patients and we can manage them by watching them carefully_"
Increase in C-section rates appears to relate to educational level. If the
medical. personnel have only a cursory knowledge of PH,R patterns and PSB pH
PRr1217-101	 -3-
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sampling is not practiced, electronic monitoring call 	 an early C-section
when unneressary. However, at Los Angeles County Hospital, where about one-third
of all fetuses are monitored, C-section rates have remained stable at about 100
Although it is true that electronic monitoring increases costs, this fact must he
weighed against its potential for preventing deaths and minimizing the number of
individuals with birth-caused brain damage who must be maintained in public-
supported institutions for life.
According to Quilligan and others there is no such thing as a "low risk"
paLient. 5 Although populations differ, there is increasing evidence that 100%
monitoring is desirable. Quilligan points out Chat a certain number of "low
risk" patients cannot be pre-diagnosed as "high risk" until the fetus is in
danger.
Paul, in a paper entitled "Intrapartum Petal. Monitoring: Current status and the
Future,"6 indicates that the 1970S present a unique opportunity to implement new
investigations and techniques to benefit: both wother and fetus. He indicates
that this is the period for standardization of classification, instrumentation,
and data display.
For details, see "Monitoring of the Fetus," by Finster, published in August 1976,
in Anesthesiology.7
III.	 OXYGEN, CARBON DIOXIDE, AND p tl SENSORS
Before describing Cho. latest work on miniature blood gas and pit sensors, it is
well to indicate clearly the relationship between continuous FHR and FSB sampling
The purpose of the FSB pH determination is to reduce the margin of error associ-
ated with reference to the FHR patterns alone. $ Experience has shown that the
acid-base status of the infant at birth may in fact be good even though the FUR
patterns were abnormal. At this time, the two measurements are complementary--
FHR monitoring is used for preliminary screening of all cases (or at ].east all
cases at risk), and microanalysis of fetal blood is used as a guide to the
t
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obstetric management of labor once pathological changes in FHR are detected.
The problem of false positives was alluded to in the previous section--the case:
where a low fetal pH during labor does not reflect a state of fetal hypoxia.
The clinical condition of these infants at birth 1s so good (Apgar > 7) that
rapid extraction would not have been Justified.
More detailed analysis of fetal pll along with maternal pli has been suggested as
a means of obtaining a clearer clinical picture.
Roversi, for example, suggests four methods:8
1. Difference between fetal and material base deficit (F/M A 13D)--
comparison of the metabolic component of the acid—base balance.
2. Differences between maternal and fetal pH qu 40 (M/F A pll qu 40)--
pli of the blood after equilibration of CO 2
 at a P CO 2 of 40 mmlig.
3. Differences between the actual maternal and fetal pll (M/F actual A pll).
4. Materno—fetal difference in base deficit of exLracellular fluid
(M/F A BD Hb5)--base deficit cal,culaLed oil 	 basis of the amount
of red cells distributed throughout the interstitial. space, at an Hb
concentration of 5 g/100 nit (BD Hb5)
Work by Roversi, et al, indicates that the most meaningful of the various param-
eters so far suggested in M/F A 13D Hb5.
,:rom our survey of recent papers it appears Chia an additional, continuous in-
dicaLor of fetal. acid—base balance is desirab"l.c. For example, in a study by
Stalig of 4396 deliveries, FSB samples were obtained in 850 cases. 9 Fifteen
infants were born with advanced or severe metabolic acidosis, although during
labor fetal blood samples were normal. In a paper by Beard, Morris, and
Clayton, it is concluded that the :Level of fetal pH does not necessarily reveal.
either the duration or the severity of the preceding intrauterine asphyxia. 10
It is possible that a continuous indication 1109 sensor or a continuous indi-
cating PCO 2 sensor, or both, which attach to the scalp integral with the fetal
i'
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scalp ECG electrode, may provide the needed clinical indicators of fetal hy-
poxia. The use of intravascular sensors for this purpose seems inappropriate,
however, for several reasons. The first of these is the size of the sensor(s).
It is desirable to attach the sensor as early as possible, and the presenting
surface may be very small. The second hurdle is the potential for trauma;
viral and bacterial infections have been reported incidental to the use of
spiral scalp electrodes. The third problem relates to sensor calibration vs.
sterility requirements, Calibration prior to sterilization is usually not
satisfactory, because potential offsets may be induced by chemical or heat
sterilization, and calibration after sterilization is usually unsatisfactory
because of the potential for cone-minaLion. It appears that these problems can
be largely overcome through the u.e of Lranscutaneous sensors.
In this area, the work of A. and R. lluch is notable a•1 In this recent (June
1976) summarizing article, the extent to Which this sensor has application is
discussed. Not only is it valuable for fetal oxygen monitoring during delivery
but it appears valuable in postpartum monitoring of infants--especially preterm
newborns--and :in the larger arena of anesthesia, postsurgical., and intensive
care.
The functioning of a transcutaneous P0 2 electrode depends upon raising the P02
at the skin surface from its normal zero level to something approaching arterial
blood P0 2 . The work of Huch indicates that a controlled temperature increase of
the skin beneath the Clark-type 02 sensor is effective. The electrode body is
allowed to reach 45°C for adults and 44°C for prematures. This results in a 430
to 44°C skin temperature. The heat energy required to maintain this temperature
is related to capillary blood flow--i.e., an indicator of relative perfusion in
the area. The transcutaneous P0 2 (T'cP0 2 ) electrode as fabricated by Huch con-
sists of a ring-shapod silver anode heated by a coil, to provide local hyperemia.
Within the anode are three thin platinum cathodes, only 15 Um in diameter... The
working face is covered by a double membrane of Teflon and cellophane. A po-
tassium chloride electrolyte is used.
f^
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Especially good correlation between TcP0 2 and arterial P02 for neonates has
been observed by Much--r = .97. For Ob-Gyn and surgical patients, r - .92.
Time lags of no more than 10 seconds have been achieved with infants. At this
time accurate P02 readings are obtained from the fecal scalp as soon as the
cervix is diluted at least 4 cm.
In another recent paper by Hach, et a1, 12 thirty :Long-term continuous TcP02
	 r
recordings were made and compared with 132 arterial P0 2 determinations. A
linear relationship between arterial P02 and TcP02 (r = .94) was observed.
The duality of the correlation was not influenced negatively by the length
Of the Tep0 2 recordings, nor was any skin damage observed.
Others have fabricated and used transcutaneous P0 2 electrodes. Swanstrom has
used this method for monitoring the newborn :infant with acceptable results.13
Ile expressed concern about thethe possibility of a vasoconstriction confusing the
readings, although this problem did not occur during this study.
Scacci, et 111, 14 have used the transcutaneous oxygen electrode and feel that it
is a satisfactory indicator of changes in arterial P02 in the fetus with good
peripheral. circulation. They found that it is possible Lo estimate PaO 2 over
intervals of 24 hours with an average error of 15 mmlig.
Attractive as a continuous measuring 1102 electrode is for assessing fetal. hy-
poxia Status, the final determination of the extent of fetal acid-base status
is made by pH or PCO 2 analysis of fetal capillary blood. The work with trans-
cutaneous P0 2 electrodes has stimulated work with transcutaneous PCO2 electrodes
of similar geometry. The work by lleran, Iluxtable, and Sperling demonstrates a
departure from the common PCO 2 electrode. 15 Traditionally, membrane PCo 2 elec-
trodes have been constructed using the principle of Stow--a glass pll electrode
and reference electrode are bathed in bicarbonate buffer and covered with a
membrane di.ffuSible to CO2 molecules. This carbon dioxide reacts with the
buffer which dissociates to 11 and IICO 3 . The resultant pH change is sensed by
the pH electrode and expressed as a PCO 2 change. Reran bass fabri.caLed and
tested an antimony-anL-itnony oxide (Sb-SBOx) electrode against a silver-silver
f.7;
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chloride (Ag-AgCl) reference electrode. 'rile resulting sensor is similar to the
Much transeutaneous P0 2 electrode--having a heater with ther.mistor for thermal
control, 3 Sb-SROx electrodes within a central structure, and Ag-AgCI reference.
A 13-pm Teflon membrane is used with the standard CO2 electrolyte (water Na"CO3,
KC1.). In vivo studies have been performed on rabbits and human volunteers.
Response time of the sensor appears to be slightly .less than w minutes (95%).
Good results were obtained between To 
PCO2 and arterial PCO 2 in the rabbit. The
equation of the line TO CO2 = arterial PCO 2 x 1.029 - 4.39, The standard devia-
tion of the points along the line was 4.140.
pit measurements would also be of value in the assessment of acid-base status.
Although a continuous indication of fetal scalp blood pit would complete the
standard acid-base measurement, the practicality of constructing a pit electrode
of fragile glass is questionable. Small percutaneous pit sensors for muscle
surface measurements have been fabric:1ed and are commercially available. A
dual-function pit and PCO2 in vivo sensor has also been reported on by Coon,
et al. 16 This device is intended for intravascular application.
A paper by Stam, et al, 17 describes a subcutaneous pit sensor for fetal scalp
application. The glass pit sensor has spiral springs for insertion into the
fetal. scalp. Good correlation between subcutaneous pit mean value and capillary
blood mean value produced a correlation coefficient of r = .965 (P<0,001). Be-
cause pit measurements are of necessity invasive, however, there are problems
associated with calibration and maintenance of sterility.
In theory, the new field-effect transistors that are chemical or ion sensitive
could measure pit or 9* ion concentration. Rased on limited experience with
these sensors, it appears that considerable research is required before they
are directly applicable to the fetal monitoring arena,18,1.9
When manufacturability, ease of calibration (calibration must result in a
sterile sensor ready for application), and ruggedness are considered, it appears
that the membrane covered trans cutaneous P0 2 and PCO2 sensors have some consid-
erable advantages. The fetal scalp ECG electrode appears to be an easy
addition to the P027PCO2 sensor assembly. Possibly a capacitively-coupled
FR-1217-101
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electrode adjacent to the mcwf! Mane covered unit would provide the necessary
simultaneous RCG signals with minimum cervical dilation.
TV.	 CONCLUSTONS AND RRCONDIRNDATT.ONS
If the desired configuration of an intrapartum monitoring system is a single
sensor capable of measuring multiple determinations of fetal health, we must
conclude that a satisfactory sensor is not currently available. Recent reports
and research in progress indicate that the elements of such a sensor are well
advanced in their development states. The obvious next stop is to create a
multiparametric sensor capable of making simultaneous measurements from a
single point of attachment.
r
V.	 A COMBINED PETAL MONITORING PROBE
A combination fetal. monitoring electrode could make a
to the clinical. management of the fetus and neonate.
electrode to satisfy clinical requirements, a number
must be initially identified and carefully adhered to
development phase.
significant contribution
In order for such an
Df design objectives
throughout the
The following list of design objectives is provided for consideration:
1. The probe must be rugged and durable--or it must be Inexpensive and
disposed of after a single usa.
2. It must be carefully integrated and sufficiently small so moni-
toring can begin very early in iabor-- lire f crab ly when the cervix
dilation is no more than 2 cm.
..r
3. Calibration prior to use must be quite straightforward. The probe
could be automatically calibrated for P0 2 and P CO2 by some form of
closed loop procedure--for example, the probe mighP be immersed in
a tonomeCered_mixture or exposed to a sterile gas Mixture with con-
tinuous and automatic adjustment of the 02 and CO 2 amplifiers.
PR-1217-101-	 -S-
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4. Sterility must be maintained during calibration.
5. The entire probe assembly must be totally isolated from the readout/
display. Optical isolators now effectively isolate into the kilovolt
region and may offer a solution to this problem.
6. If the probe is reused, minimum routine maintenance must be adequate
to maintain the probe for many months--in other words, there can be
	
i
no changing of membrane, adding to electrolyte, etc. Beckman's
experience with pregelled P02 sensors proves without a doubt the
J
	 wisdom of this approach in clinical medicine.
A desirable approach for the development of the probe would be for both blood
gas sensors to share a common cathode, electrolyte, and membrane. Since no
research to our knowledge has been done on a combined Clark PO2 and SbSBOx
PCO 9 electrode, this should be further explored. It has been established,
however, that the standard Clark electrode and Stow-Severinghaus electrode
can operate with a common electrolyte.
Since FHR is vital to the fetal monitoring, a combined electrode should have
built-in provision for detecting the fetal ECG integral.
The spiral ECG electrode has become popular in recent years, and currently
offers the highest quality ECG signal with the safest attachment concept. Huch
has fabricated a transcutaneous P02 electrode with a silver ring ECG electrode.
The entire unit is held to the scalp with vacuum. The vacuum approach is
appealing since it causes little tissue damage. It would be desirable to avoid
puncturing the fetal scalp for two reasons:
1. less danger of infection.
2. Fluid exudation would not interfere with the operation of the
membrane sensors.
I
Reliability of any fetal ECG electrode not producing a puncture is open to
question. However, a combination probe must not under any circumstances de-
grade the quality of the FHR traces--the most reliable and dependable aspect
of present-day fetal monitoring.
I	
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We feel that a combined sensor assembly would offer the most significant
advance for the clinician. The active fetal ECG electrode and Its reference
electrode would be integrated into Clio sensor body. A dual L'ransCUL'aneous PO 
and PCO2
 electrode with common elements would complete the sensor assembly. The
significant technical objective would be to design and fabricate a functioning
P02-PCO2 unit with common gel electrolyte, common membrane materials, and shared 	
t ,
Ag-AgCl referonce or anode. A single cathode structure is proposed with gold or
platinum for the polarographic 0 2 sensor, and either Sb-SUOx material or glass
	 j
bulb for Clio CO2 sensor.
The choice of ancimony oxide vs pll glass for P CO ,) will depend on investigations
presently under way by Iluxtable and lleran (personal communication). Vacuum
attachment concepts should be initially explored--an Ag-AgCI surface should
provide the high quality fetal ECG signal, so necessary for fetal artifact-free
PIIR patterns.
A sketch of the proposed sensor is shown in Figure 1.
Figure 1, which includes details of the tissue contacting portion of Clio pro-
posed sensor only, indicates the following key elements:
1. Fetal CissaL temperature control section--including thermistor and
heating element.
2. An Ag-AgCl active fetal. ECG electrode--with reference electrode
depicted.
3. A gelled electrolyte with large reservoir for maximum sensor life
at elevated operating temperature (42 0 to 44°C).
4. A temperature-indicating thermistor for compensation of membrane
temperature coefficlent.
a
5. A common Ag-AgCI anode structure within the electrolyte. 	 1
i
6. Antimony-Antimony oxide elements for PCO 2 measurements.
1
7. A gold or platinum cathode for polarograpic 02 sensors.
FR-1217-1.01	 -10-
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Figure 2 is a block diagram of the readout-control circuit which would be suit-
able for commercial use. To meet- the requirements of the Food & Drug Adminis-
tration (FDA) for this class of instr , unent, isolated power and recorder drive
circuits are required (Section VI).
The proposed fetal monitoring system would include 4 channels of output. A
final commercial package would most likely integrate the 4 channels with the
readout and control circuits to provide a simple and useful package. A micro-
processor for control logic would contribute to the clinical usability of the
final commercial product.
We suggest that initial efforts be directed towards designing, fabricating, and
evaluating the patient-contacting elements shown in Figure 2. To maximize this
effort, as many as possible of the blocks depicted in the condition circuits
section should be purchased off the shelf. For example, blocks 5 and 6 essen-
tially exist as commercial fetal monitoring units, available for $5000 to $8000.
Block 4, the Membrane Temperature Amplifier, could be obtained off the shelf.
Block 2, the Tissue Temperature Controller, is available as a standard product
and could be used directly with minor modifications. Block 3--the P0 2 and PCO2
amplifiers--must be developed integral with the P0 2 and PCO 2 sensors to achieve
the proper impedance, biasing, and control. Standard digital, panel meters could
be used in the initial effort.
Although the combined FSCC/P02/PCO 2 sensor must be evaluated and I.roved in an
obstetrical. environment, we believe initial evaluation should begin on animals
and adult humans. The system, as described, should go through a rigorous eval-
uation using animals and adult humans before being applied to the fetus. The
data obtained in such a manner would probably be required to meet FDA guidelines
for a product of this nature.
f
VI.	 REGULATIONS AFFECT'I'NG DEVELOPMENT
The type of instrumentation discussed in this report is expected to be subject
to FDA Medical Devices Amendments of 1.976. The Amendments established three
FR-1217-101
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levels of regulatory control of medical, devices: Class I (General Control);
Class II (Performance Standards): and Class III (Premarket Approval). Classi-
fication of medical devices under the Amendments has not been completed, but
based on classification activities to date, it would appear that a fetal mon-
itoring device would be at least Class II and could possibly be Class I'II.
Until device classification is completed by the FDA, all new devices (not on
the market prior to May 28, 1976) that are life-supporting or life-sustaining
are presumed to be Class III until a less rigorous classification can be
justified.
The Class II level of regulatory control requires a device to be manufactured in
accordance with a federally-established performance standard. The r±rformance
standard established by the FDA, where necessary to provide reasonable assurance
of safe and effective performance of device, will include:
1. Provisions for the detailed performance requirements of the device and
its compatibility with power systems and connections;
2. Provisions for the testing of the device;
3. Provisions for the measurement of the performance characteristics of
the device;
d.	 Provisions that the results of the device testing show that the device
is in conformance with the standard for which the test was required;
and
5.	 Provisions fer the .labeling for the device.
The performance standard that wills eventually evolve will normally be effective
one year after its publication in the Federal Register unless the FDA determines
that an earlier effective date is necessary for the protection of the public
health and safety. Until performance standards are published for devices in
Class 11, unless otherwise specified, all such devices will. be subject to the
more general controls of Class I which consist mainly of good manufacturing
practices. The Class III level of regulatory control. requires FDA review and
approval of data oil
	
and effectiveness of a medical. device prior to
7—
f
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Placing the device on the market. Detailed scientific studies will be required
from which the FDA can arrive at conclusions regarding device safety and
effectiveness.
i
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